Ethanol exposure reduces the density of the low-affinity nerve growth factor receptor (p75) on pheochromocytoma (PC12) cells. 1996

J Luo, and J R West, and N J Pantazis
Department of Anatomy, Bowen Science Building, University of Iowa College of Medicine, University of Iowa 52242, USA.

Although ethanol is detrimental to the developing nervous system, the mechanism(s) by which ethanol produces neuronal damage is (are) not clear. One potential mechanism is ethanol-induced inhibition of neurotrophic support. This study utilized an in vitro model, pheochromocytoma PC12 cells, to examine the effect of ethanol on the nerve growth factor (NGF) receptor. NGF binding studies indicated that ethanol exposure (400 mg/dl for 4 days) reduced the density of the low-affinity (p75) NGF receptor on PC12 cells, but had no effect on the density of the high-affinity NGF receptor. The equilibrium dissociation constants (Kd) for both the low-affinity and high-affinity NGF receptors were unaffected by ethanol. Low-affinity NGF binding is mediated by the p75 component of the NGF receptor. Quantification of p75 by immunoprecipitation revealed that ethanol reduced the level of p75 in PC12 cells. However, Northern analysis indicated that the p75 mRNA was not reduced by ethanol exposure, raising the possibilities that ethanol inhibited translation of p75 or incorporation of the p75 protein into the plasma membrane. This work is consistent with the hypothesis that ethanol's detrimental effects may be produced in part by inhibition of neurotrophic support at the receptor level.

UI MeSH Term Description Entries
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D016716 PC12 Cells A CELL LINE derived from a PHEOCHROMOCYTOMA of the rat ADRENAL MEDULLA. PC12 cells stop dividing and undergo terminal differentiation when treated with NERVE GROWTH FACTOR, making the line a useful model system for NERVE CELL differentiation. Pheochromocytoma Cell Line,Cell Line, Pheochromocytoma,Cell Lines, Pheochromocytoma,PC12 Cell,Pheochromocytoma Cell Lines
D017475 Receptors, Nerve Growth Factor Cell surface receptors that bind NERVE GROWTH FACTOR; (NGF) and a NGF-related family of neurotrophic factors that includes neurotrophins, BRAIN-DERIVED NEUROTROPHIC FACTOR and CILIARY NEUROTROPHIC FACTOR. NGF Receptors,Nerve Growth Factor Receptors,Neurotrophic Factor Receptor,Neurotrophin Receptor,Receptors, NGF,Receptors, Neurotrophin,Neurotrophin Receptors,Receptors, Neurotrophic Factor,Neurotrophic Factor Receptors,Receptor, Neurotrophic Factor,Receptor, Neurotrophin

Related Publications

J Luo, and J R West, and N J Pantazis
September 2002, Journal of neuroscience research,
J Luo, and J R West, and N J Pantazis
December 1982, Biochimica et biophysica acta,
J Luo, and J R West, and N J Pantazis
October 2005, Brain research. Molecular brain research,
J Luo, and J R West, and N J Pantazis
July 1996, Journal of neuroscience research,
J Luo, and J R West, and N J Pantazis
December 1999, FEBS letters,
J Luo, and J R West, and N J Pantazis
December 2008, Journal of cellular and molecular medicine,
J Luo, and J R West, and N J Pantazis
January 2021, Frontiers in pediatrics,
J Luo, and J R West, and N J Pantazis
August 1991, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!